FDA Clears ResolutionMD for Android Devices

Article

Calgary Scientific Inc. has received FDA clearance for its software for diagnostic medical image viewing on Android mobile devices.

Calgary Scientific Inc. has received FDA clearance for its software for diagnostic medical image viewing on Android mobile devices.

ResolutionMD allows physicians to securely view patient images from computers and mobile devices, collaborate with practitioners, and make diagnoses in real time, according to the company. Patient information is not stored on the device. A 2012 Mayo Clinic study found that radiologists using ResolutionMD versus a PACS workstation accessed CT scans of stroke victims 24 percent faster, representing 11 minutes per patient, the company said.

Calgary Scientific is the first company to receive FDA clearance for diagnostic image viewing on a variety of Android devices, according to the company. ResolutionMD Web received FDA clearance in 2009, and in 2011 it was cleared for use on iPhone and iPad. ResolutionMD is also CE marked for distribution in Europe and licensed by Health Canada.  

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.